Its LDH-D isoenzyme is expressed in patients with uterine sarcomas and the overexpression of LDH-A and LDH-D may act as a potential prognostic biomarker in women with those tumors [124]. The gene discussed is LDHD; the disease is uterine corpus sarcoma.